Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Opioid Pain Treatment
1.2 Key Market Segments
1.2.1 Non-Opioid Pain Treatment Segment by Type
1.2.2 Non-Opioid Pain Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-Opioid Pain Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Non-Opioid Pain Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-Opioid Pain Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-Opioid Pain Treatment Market Competitive Landscape
3.1 Global Non-Opioid Pain Treatment Sales by Manufacturers (2019-2024)
3.2 Global Non-Opioid Pain Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Opioid Pain Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Opioid Pain Treatment Sales Sites, Area Served, Product Type
3.6 Non-Opioid Pain Treatment Market Competitive Situation and Trends
3.6.1 Non-Opioid Pain Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Opioid Pain Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-Opioid Pain Treatment Industry Chain Analysis
4.1 Non-Opioid Pain Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-Opioid Pain Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-Opioid Pain Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Opioid Pain Treatment Sales Market Share by Type (2019-2024)
6.3 Global Non-Opioid Pain Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Non-Opioid Pain Treatment Price by Type (2019-2024)
7 Non-Opioid Pain Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Opioid Pain Treatment Market Sales by Application (2019-2024)
7.3 Global Non-Opioid Pain Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Opioid Pain Treatment Sales Growth Rate by Application (2019-2024)
8 Non-Opioid Pain Treatment Market Segmentation by Region
8.1 Global Non-Opioid Pain Treatment Sales by Region
8.1.1 Global Non-Opioid Pain Treatment Sales by Region
8.1.2 Global Non-Opioid Pain Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Opioid Pain Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Opioid Pain Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Opioid Pain Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Opioid Pain Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Opioid Pain Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan PLC
9.1.1 Allergan PLC Non-Opioid Pain Treatment Basic Information
9.1.2 Allergan PLC Non-Opioid Pain Treatment Product Overview
9.1.3 Allergan PLC Non-Opioid Pain Treatment Product Market Performance
9.1.4 Allergan PLC Business Overview
9.1.5 Allergan PLC Non-Opioid Pain Treatment SWOT Analysis
9.1.6 Allergan PLC Recent Developments
9.2 Canopy Growth
9.2.1 Canopy Growth Non-Opioid Pain Treatment Basic Information
9.2.2 Canopy Growth Non-Opioid Pain Treatment Product Overview
9.2.3 Canopy Growth Non-Opioid Pain Treatment Product Market Performance
9.2.4 Canopy Growth Business Overview
9.2.5 Canopy Growth Non-Opioid Pain Treatment SWOT Analysis
9.2.6 Canopy Growth Recent Developments
9.3 Medical Marijuana Inc.
9.3.1 Medical Marijuana Inc. Non-Opioid Pain Treatment Basic Information
9.3.2 Medical Marijuana Inc. Non-Opioid Pain Treatment Product Overview
9.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Product Market Performance
9.3.4 Medical Marijuana Inc. Non-Opioid Pain Treatment SWOT Analysis
9.3.5 Medical Marijuana Inc. Business Overview
9.3.6 Medical Marijuana Inc. Recent Developments
9.4 Panag Pharma Inc.
9.4.1 Panag Pharma Inc. Non-Opioid Pain Treatment Basic Information
9.4.2 Panag Pharma Inc. Non-Opioid Pain Treatment Product Overview
9.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Product Market Performance
9.4.4 Panag Pharma Inc. Business Overview
9.4.5 Panag Pharma Inc. Recent Developments
9.5 Tilray
9.5.1 Tilray Non-Opioid Pain Treatment Basic Information
9.5.2 Tilray Non-Opioid Pain Treatment Product Overview
9.5.3 Tilray Non-Opioid Pain Treatment Product Market Performance
9.5.4 Tilray Business Overview
9.5.5 Tilray Recent Developments
9.6 Aphria Inc.
9.6.1 Aphria Inc. Non-Opioid Pain Treatment Basic Information
9.6.2 Aphria Inc. Non-Opioid Pain Treatment Product Overview
9.6.3 Aphria Inc. Non-Opioid Pain Treatment Product Market Performance
9.6.4 Aphria Inc. Business Overview
9.6.5 Aphria Inc. Recent Developments
9.7 Bedrocan
9.7.1 Bedrocan Non-Opioid Pain Treatment Basic Information
9.7.2 Bedrocan Non-Opioid Pain Treatment Product Overview
9.7.3 Bedrocan Non-Opioid Pain Treatment Product Market Performance
9.7.4 Bedrocan Business Overview
9.7.5 Bedrocan Recent Developments
9.8 Cara Therapeutics
9.8.1 Cara Therapeutics Non-Opioid Pain Treatment Basic Information
9.8.2 Cara Therapeutics Non-Opioid Pain Treatment Product Overview
9.8.3 Cara Therapeutics Non-Opioid Pain Treatment Product Market Performance
9.8.4 Cara Therapeutics Business Overview
9.8.5 Cara Therapeutics Recent Developments
9.9 Centrexion Therapeutics
9.9.1 Centrexion Therapeutics Non-Opioid Pain Treatment Basic Information
9.9.2 Centrexion Therapeutics Non-Opioid Pain Treatment Product Overview
9.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Product Market Performance
9.9.4 Centrexion Therapeutics Business Overview
9.9.5 Centrexion Therapeutics Recent Developments
9.10 CHT Medical
9.10.1 CHT Medical Non-Opioid Pain Treatment Basic Information
9.10.2 CHT Medical Non-Opioid Pain Treatment Product Overview
9.10.3 CHT Medical Non-Opioid Pain Treatment Product Market Performance
9.10.4 CHT Medical Business Overview
9.10.5 CHT Medical Recent Developments
9.11 Cronos Group
9.11.1 Cronos Group Non-Opioid Pain Treatment Basic Information
9.11.2 Cronos Group Non-Opioid Pain Treatment Product Overview
9.11.3 Cronos Group Non-Opioid Pain Treatment Product Market Performance
9.11.4 Cronos Group Business Overview
9.11.5 Cronos Group Recent Developments
9.12 GW Pharmaceuticals
9.12.1 GW Pharmaceuticals Non-Opioid Pain Treatment Basic Information
9.12.2 GW Pharmaceuticals Non-Opioid Pain Treatment Product Overview
9.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Product Market Performance
9.12.4 GW Pharmaceuticals Business Overview
9.12.5 GW Pharmaceuticals Recent Developments
9.13 Medropharm Gmbh
9.13.1 Medropharm Gmbh Non-Opioid Pain Treatment Basic Information
9.13.2 Medropharm Gmbh Non-Opioid Pain Treatment Product Overview
9.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Product Market Performance
9.13.4 Medropharm Gmbh Business Overview
9.13.5 Medropharm Gmbh Recent Developments
9.14 US Worldmeds LLC
9.14.1 US Worldmeds LLC Non-Opioid Pain Treatment Basic Information
9.14.2 US Worldmeds LLC Non-Opioid Pain Treatment Product Overview
9.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Product Market Performance
9.14.4 US Worldmeds LLC Business Overview
9.14.5 US Worldmeds LLC Recent Developments
10 Non-Opioid Pain Treatment Market Forecast by Region
10.1 Global Non-Opioid Pain Treatment Market Size Forecast
10.2 Global Non-Opioid Pain Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Opioid Pain Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Non-Opioid Pain Treatment Market Size Forecast by Region
10.2.4 South America Non-Opioid Pain Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Opioid Pain Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Non-Opioid Pain Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-Opioid Pain Treatment by Type (2025-2030)
11.1.2 Global Non-Opioid Pain Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-Opioid Pain Treatment by Type (2025-2030)
11.2 Global Non-Opioid Pain Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Non-Opioid Pain Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Non-Opioid Pain Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
